Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY28.32 CNY
Change Today +0.04 / 0.14%
Volume 4.9M
As of 3:00 AM 04/30/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by WALVAX BIOTECHNOLOGY CO-A (300142) in the last 6 months

Announced 03/21/15
85.00M for Genor BioPharma Co., Ltd.
Merger/Acquisition

Walvax Biotechnology Co.,Ltd (SZSE:300142) agreed to acquire an additional 8.83% stake in Genor BioPharma Co., Ltd. from Wison (China) Investment Co., Ltd. for CNY 85 million on March 19, 2015. An equity transfer agreement with Wison (China) Investment Co., Ltd. will be signed. Genor Biopharma had total assets of CNY 105.74 million, total liabilities of CNY 116.22 million, net liabilities of CNY 10.48 million, revenue of CNY 0.39 million and net loss of CNY 63.58 million ...
Read More


300142's price was unchanged after the transaction was announced on 03/21/15.
Investor / Buyer
Walvax Biotechnology Co.,Ltd
Creditor / Lender
Wison (China) Investment Co., Ltd.
 
Announced 12/6/14
Guangdong Wellen Biological Pharmaceutical Co., Ltd.
Merger/Acquisition

Walvax Biotechnology Co.,Ltd (SZSE:300142) signed a cooperative agreement to acquire 21% stake in Guangdong Wellen Biological Pharmaceutical Co., Ltd. from Guizhou-based biotechnology company and Shantou-based industry company on December 6, 2014.


300142's price was unchanged after the transaction was announced on 12/6/14.
Investor / Buyer
Walvax Biotechnology Co.,Ltd
 
Announced 11/13/14
350.00M for Chongqing Beining Biological Pharmaceutical Co., Ltd.
Merger/Acquisition

Walvax Biotechnology Co.,Ltd (SZSE:300142) agreed to acquire Chongqing Beining Biological Pharmaceutical Co., Ltd. from Shihezi Longchen Investment Partnership (Limited Partnership) and Yuan Yong for CNY 350 million on November 12, 2014. Under the terms of the deal, Walvax Biotechnology Co.,Ltd will pay CNY 178.5 million to Shihezi Longchen Investment Partnership for 51% stake and CNY 171.5 million to Yuan Yong for 49% stake in Chongqing Beining Biological Pharmaceutical ...
Read More


300142's price was unchanged after the transaction was announced on 11/13/14.
Investor / Buyer
Walvax Biotechnology Co.,Ltd
Creditor / Lender
Shihezi Longchen Investment Partnership (Limited Partnership)
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300142:CH CNY28.32 CNY +0.04

300142 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 300142.
View Industry Companies
 

Industry Analysis

300142

Industry Average

Valuation 300142 Industry Range
Price/Earnings 92.9x
Price/Sales 18.7x
Price/Book 4.6x
Price/Cash Flow 92.5x
TEV/Sales 14.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WALVAX BIOTECHNOLOGY CO-A, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.